Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233–54.

Article  PubMed  Google Scholar 

Pretzsch E, Bosch F, Neumann J, Ganschow P, Bazhin A, Guba M, et al. Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread. J Oncol. 2019;2019:7407190.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5:22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Price TJ. Advanced colorectal cancer treatment options beyond standard systemic therapy. Lancet Oncol. 2017;18:157–9.

Article  PubMed  Google Scholar 

Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N. Engl J Med. 2005;352:476–87.

Article  CAS  PubMed  Google Scholar 

Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124–34.

Article  CAS  PubMed  Google Scholar 

Hayat H, Dwan BF, Gudi M, Bishop JO, Wang P. A Concise Review: The Role of Stem Cells in Cancer Progression and Therapy. OncoTargets Ther. 2021;14:2761–72.

Article  Google Scholar 

Atashzar MR, Baharlou R, Karami J, Abdollahi H, Rezaei R, Pourramezan F, et al. Cancer stem cells: A review from origin to therapeutic implications. J Cell Physiol. 2020;235:790–803.

Article  CAS  PubMed  Google Scholar 

Munro MJ, Wickremesekera SK, Peng L, Tan ST, Itinteang T. Cancer stem cells in colorectal cancer: a review. J Clin Pathol. 2018;71:110–6.

Article  CAS  PubMed  Google Scholar 

Zhou HM, Zhang JG, Zhang X, Li Q. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduct Target Ther. 2021;6:62.

Article  PubMed  PubMed Central  Google Scholar 

Frank MH, Wilson BJ, Gold JS, Frank NY. Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies. Gastroenterology. 2021;160:1947–60.

Article  CAS  PubMed  Google Scholar 

Huang JL, Oshi M, Endo I, Takabe K. Clinical relevance of stem cell surface markers CD133, CD24, and CD44 in colorectal cancer. Am J Cancer Res. 2021;11:5141–54.

CAS  PubMed  Google Scholar 

van Schaijik B, Davis PF, Wickremesekera AC, Tan ST, Itinteang T. Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review. J Clin Pathol. 2018;71:88–91.

Article  PubMed  Google Scholar 

Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2017;16:115–30.

Article  CAS  PubMed  Google Scholar 

Gonzalez F, Boue S, Belmonte Izpisua. JC. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet. 2011;12:231–42.

Article  CAS  PubMed  Google Scholar 

Sharma A, Sances S, Workman MJ, Svendsen CN. Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery. Cell Stem Cell. 2020;26:309–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Kasai T, Li Y, Sugii Y, Jin G, Okada M, et al. A model of cancer stem cells derived from mouse induced pluripotent stem cells. PloS One. 2012;7:e33544.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan T, Mizutani A, Chen L, Takaki M, Hiramoto Y, Matsuda S, et al. Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles. J Cancer. 2014;5:572–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shaheen S, Ahmed M, Lorenzi F, Nateri AS. Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer. Stem Cell Rev Rep. 2016;12:492–9.

Article  CAS  PubMed  Google Scholar 

Kaur M, Velmurugan B, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia. 2010;12:415–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu S, Qiu Y, Shao Y, Yin S, Wang R, Pang X, et al. Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3. Front Pharm. 2018;9:881.

Article  Google Scholar 

Yang M, Liu X, Meng F, Zhang Y, Wang M, Chen Y, et al. The rs7911488-T allele promotes the growth and metastasis of colorectal cancer through modulating miR-1307/PRRX1. Cell Death Dis. 2020;11:651.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA. 2010;107:3722–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong B, Ma L, Hu X, Zhang C, Cheng Y. Characterization of side population cells isolated from the colon cancer cell line SW480. Int J Oncol. 2014;45:1175–83.

Article  CAS  PubMed  Google Scholar 

Ribatti D, Tamma R, Annese T. Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. Transl Oncol. 2020;13:100773.

Article  PubMed  PubMed Central  Google Scholar 

Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.

Article  CAS  PubMed  Google Scholar 

Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611–29.

Article  PubMed  PubMed Central  Google Scholar 

Lizarraga-Verdugo E, Avendano-Felix M, Bermudez M, Ramos-Payan R, Perez-Plasencia C, Aguilar-Medina M. Cancer Stem Cells and Its Role in Angiogenesis and Vasculogenic Mimicry in Gastrointestinal Cancers. Front Oncol. 2020;10:413.

Article  PubMed  PubMed Central  Google Scholar 

Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.

Article  CAS  PubMed  Google Scholar 

Chen H, Liu H, Qing G. Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduct Target Ther. 2018;3:5.

Article  PubMed  PubMed Central  Google Scholar 

Llombart V, Mansour MR. Therapeutic targeting of “undruggable” MYC. EBioMedicine. 2022;75:103756.

Article  CAS  PubMed  Google Scholar 

Fatma H, Maurya SK, Siddique HR. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance. Semin Cancer Biol. 2022;83:166–76.

Article  CAS